Abvc Biopharma Inc (ABVC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,327 | 864 | 717 | 1,392 | 6,565 |
| Marketable Securities | 64 | 65 | 79 | 76 | 108 |
| Receivables | N/A | N/A | 760 | 856 | 426 |
| Inventories | N/A | N/A | N/A | N/A | 26 |
| Other current assets | 763 | 1,155 | 0 | 514 | 0 |
| TOTAL | $2,501 | $2,180 | $1,657 | $2,987 | $7,654 |
| Non-Current Assets | |||||
| PPE Net | 12,835 | 511 | 569 | 574 | 526 |
| Investments And Advances | 3,003 | 3,384 | 3,803 | 3,681 | 2,086 |
| Other Non-Current Assets | 2,722 | 1,465 | 1,756 | 2,338 | 3,433 |
| TOTAL | $18,561 | $5,360 | $6,128 | $6,592 | $6,044 |
| Total Assets | $21,062 | $7,540 | $7,785 | $9,580 | $13,698 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 106 | 773 | 174 | 360 | 393 |
| Accrued Expenses | 4,162 | 3,509 | 3,548 | 2,910 | 1,301 |
| Other current liabilities | 13 | 81 | 80 | 11 | 11 |
| TOTAL | $6,164 | $6,558 | $6,102 | $5,544 | $3,692 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 2,069 | 615 | 922 | 689 | 332 |
| TOTAL | $1,601 | $259 | $429 | $800 | $1,135 |
| Total Liabilities | $7,765 | $6,816 | $6,531 | $6,343 | $4,828 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 25,440 | 15,778 | 10,560 | 3,308 | 3,031 |
| Common Shares | 25 | 14 | 8 | 3 | 29 |
| Retained earnings | -76,858 | -68,950 | -64,047 | -54,904 | -37,942 |
| Other shareholders' equity | 3,123 | 65 | 314 | -800 | -2,331 |
| TOTAL | $13,298 | $724 | $1,254 | $3,236 | $8,870 |
| Total Liabilities And Equity | $21,062 | $7,540 | $7,785 | $9,580 | $13,698 |